Evidence map›Paper›PMID 33941243›Full record

ArticleGenome biology2021

Deep sequencing of pre-translational mRNPs reveals hidden flux through evolutionarily conserved alternative splicing nonsense-mediated decay pathways.

Carrie Kovalak, Scott Donovan, Alicia A Bicknell, Mihir Metkar, Melissa J Moore

Open access · goldAbstract read
In one paragraph

Article in Genome biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. The physiology of alternative splicing.Nature reviews. Molecular cell biology · 2023
    Review
  11. Article
  12. Bilayer Forming Phospholipids as Targets for Cancer Therapy.International journal of molecular sciences · 2022
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Carrie KovalakRNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, 01605, USA.
Scott DonovanPresent Address: Moderna, 200 Technology Square, Cambridge, MA, 02139, USA.
Alicia A BicknellPresent Address: Moderna, 200 Technology Square, Cambridge, MA, 02139, USA.
Mihir MetkarRNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, 01605, USA.
Melissa J MooreRNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, 01605, USA. melissa.moore@umassmed.edu.
University of Massachusetts Chan Medical School · USModerna Therapeutics (United States) · US

Funding

The second step of pre-mRNA splicingR01GM053007 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MOORE, MELISSA J. · 1995 to 2018
$5.6M
Howard Hughes Medical InstituteNIGMS NIH HHS R01 GM053007NIH HHS RO1-GM53007
6 · The paper itself

Abstract

backgroundAlternative splicing, which generates multiple mRNA isoforms from single genes, is crucial for the regulation of eukaryotic gene expression. The flux through competing splicing pathways cannot be determined by traditional RNA-Seq, however, because different mRNA isoforms can have widely differing decay rates. Indeed, some mRNA isoforms with extremely short half-lives, such as those subject to translation-dependent nonsense-mediated decay (AS-NMD), may be completely overlooked in even the most extensive RNA-Seq analyses.

resultsRNA immunoprecipitation in tandem (RIPiT) of exon junction complex components allows for purification of post-splicing mRNA-protein particles (mRNPs) not yet subject to translation (pre-translational mRNPs) and, therefore, translation-dependent mRNA decay. Here we compare exon junction complex RIPiT-Seq to whole cell RNA-Seq data from HEK293 cells. Consistent with expectation, the flux through known AS-NMD pathways is substantially higher than that captured by RNA-Seq. Our RIPiT-Seq also definitively demonstrates that the splicing machinery itself has no ability to detect reading frame. We identify thousands of previously unannotated splicing events; while many can be attributed to splicing noise, others are evolutionarily conserved events that produce new AS-NMD isoforms likely involved in maintenance of protein homeostasis. Several of these occur in genes whose overexpression has been linked to poor cancer prognosis.

conclusionsDeep sequencing of RNAs in post-splicing, pre-translational mRNPs provides a means to identify and quantify splicing events without the confounding influence of differential mRNA decay. For many known AS-NMD targets, the nonsense-mediated decay-linked alternative splicing pathway predominates. Exon junction complex RIPiT-Seq also revealed numerous conserved but previously unannotated AS-NMD events.

Indexed as

Alternative SplicingBiological EvolutionGene Expression RegulationHigh-Throughput Nucleotide SequencingNonsense Mediated mRNA DecayComputational BiologyGene LibraryHEK293 CellsHumansMolecular Sequence AnnotationRibonucleoproteinsRNA Processing, Post-Transcriptionalmessenger ribonucleoproteinRibonucleoproteinsAS-NMDExon junctionsmRNA isoformsPre-translational mRNPsRIPiT-SeqSplicing noise

Identifiers

PMID33941243
PMCPMC8091538
OpenAlexW3158610628

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.